Zacks Investment Research upgraded shares of NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) from a sell rating to a hold rating in a research note issued to investors on Thursday morning, Zacks.com reports.

According to Zacks, “Nissan Chemical Corporation is a chemical manufacturing company. It offers melamine, sulfuric acid, nitric acid and ammonia; fine chemicals, including special epoxy, flame retardant and disinfectant. Nissan Chemical Corporation, formerly known as Nissan Chemical Industries Ltd., is based in Tokyo, Japan. “

Shares of NNCHY stock opened at $45.19 on Thursday. The company has a current ratio of 3.10, a quick ratio of 1.90 and a debt-to-equity ratio of 0.01. The stock’s fifty day moving average price is $43.25. The firm has a market capitalization of $6.73 billion, a P/E ratio of 25.39, a P/E/G ratio of 2.26 and a beta of 0.53. NISSAN CHEM IND/ADR has a 12 month low of $41.85 and a 12 month high of $54.81.

NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) last issued its earnings results on Wednesday, May 15th. The company reported $0.64 EPS for the quarter. The firm had revenue of $572.13 million for the quarter. As a group, equities analysts expect that NISSAN CHEM IND/ADR will post 2 earnings per share for the current fiscal year.

NISSAN CHEM IND/ADR Company Profile

Nissan Chemical Corporation engages in chemicals, performance materials, agricultural chemicals, pharmaceuticals, and advanced materials and planning businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, a urea solution; FINEOXOCOL, a saturated fatty alcohol and acid; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a flame retardant; Nissan Reishi, a health food; phenylphosphonic acid, a surface modifier; HI-LITE, a chlorinated isocyanulate; and OPTBEADS, a melamine-formaldehyde resin and silica.

Recommended Story: Is a Roth IRA right for you?

Get a free copy of the Zacks research report on NISSAN CHEM IND/ADR (NNCHY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for NISSAN CHEM IND/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NISSAN CHEM IND/ADR and related companies with MarketBeat.com's FREE daily email newsletter.